Angioarchitectural morphometrics of brain tumors: Are there any potential histopathological biomarkers?

Microvascular Research

Volumn 80, Issue 3, 2010, Pages 522-533

  Di Ieva, Antonio ^a  

^a Medical University of Vienna   (Austria)

Author keywords

Angioarchitecture; Angiogenesis; Biomarker; Brain tumors; Fractal analysis; Microvascular networks; Morphometrics; Multiparametric analysis

Indexed keywords

BIOLOGICAL MARKER;

ALGORITHM; ANGIOGENESIS; BRAIN BLOOD VESSEL; BRAIN TUMOR; FRACTAL ANALYSIS; HISTOPATHOLOGY; HUMAN; MORPHOMETRICS; NEURORADIOLOGY; NUCLEAR MEDICINE; PARAMETRIC TEST; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW;

ALGORITHMS; ANIMALS; BRAIN NEOPLASMS; FRACTALS; HUMANS; MICROVESSELS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; TUMOR MARKERS, BIOLOGICAL;

EID: 78249284626     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2010.09.005     Document Type: Review

References (133)

1. Abu-Eid E., Landini G. Quantification of the global and local complexity of the epithelial-connective tissue interface of normal, dysplastic, and neoplastic oral mucosae using digital imaging. Pathol. Res. Pract. 2003, 199:475-482.
2. Abu-Eid R., Landini G. Morphometrical differences between pseudo-epitheliomatous hyperplasia in granular cell tumours and squamous cell carcinomas. Histopathology 2006, 48:407-416.
3. Amyot F., Camphausen K., Siavosh A., Sackett D., Gandbakhche A. Quantitative method to study the network formation of endothelial cells in response to tumor angiogenic factors. Syst. Biol. (Stevenage) 2005, 152:61-66.
4. Avnir D., Biham O., Lidar D., Malcai O. Is the geometry of nature fractal?. Science 1998, 279:39-40. (Wash. DC).
5. Baish J.W., Jain R.K. Fractals and cancer. Cancer Res. 2000, 60:3683-3688.
6. Baish J.W., Jain R.K. Correspondence Re: Chung HW, Chung HJ. Cancer Res. 2001, 61:8347-8351.
7. Baish J.W., Gazit Y., Berk D.A., Nozue M., Baxter L.T., Jain R.K. Role of tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model. Microvasc. Res. 1996, 51:327-346.
8. Barnsley M. Fractals Everywhere 1988, Academic Press, San Diego.
9. Bear J. Dynamics of Fluids in Porous Media 1972, American Elsevier Publishing Company, New York.
10. Bernesen H.J., Rijken P., Hagemeier N.E., van der Kogel A.J. A quantitative analysis of vascularization and perfusion of human glioma xenografts at different implantation sites. Microvasc. Res. 1999, 57:244-257.
11. Bian X.W., Du L.L., Shi J.Q., Cheng Y.S., Liu F.X. Correlation of bFGF, FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas. Anal. Quant. Cytol. Histol. 2000, 22:267-274.
12. Bian X.W., Jiang X.F., Chen J.H., et al. Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas. Int. Immunopharmacol. 2006, 6:90-99.
13. Birner P., Piribauer M., Ingeborg F., et al. Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes. Brain Pathol. 2003, 13:133-143.
14. Brem S. The role of vascular proliferation in the growth of brain tumors. Clin. Neurosurg. 1976, 23:440-453.
15. Brem S., Cotran R., Folkman J. Tumor angiogenesis: a quantitative method for histologic grading. J. Natl Cancer Inst. 1972, 48:347-356.
16. Brown E.B., Campbell R.B., Tsuzuki Y., et al. In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat. Med. 2001, 7:864-868.
17. Bruner E., Mantini S., Perna A., Maffei C., Manzi G. Fractal dimension of the middle meningeal vessels: variation and evolution in Homo erectus, Neanderthals, and modern humans. Eur. J. Morphol. 2005, 42:217-224.
18. Bullitt E., Zeng D., Gerig G., et al. Vessel tortuosity and brain tumor malignancy: a blinded study. Acad. Radiol. 2005, 12:1232-1240.
19. Bullitt E., Reardon D.A., Smith J.K. A review of micro- and macrovascular analysis in the assessment of tumor-associated vasculature as visualized by MR. Neuroimage 2007, 37:116-119.
20. Bullitt E., Ewend M., Vredenburgh J., et al. Computerized assessment of vessel morphological changes during treatment of glioblastoma multiforme: report of a case imaged serially by MR over four years. Neuroimage 2009, 47:T143-151.
21. Bulnes S., Argandoña E.G., Bengoetxea H., Leis O., Ortuzar N., Lafuente J.V. The role of eNOS in vascular permeability in ENU-induced gliomas. Acta Neurochir. Suppl. 2010, 106:277-282.
22. Caserta F., Eldred W.D., Fernandez E., et al. Determination of fractal dimension of physiologically characterized neurons in two and three dimensions. J. Neurosci. Meth. 1995, 56:133-144.
23. Cassot F., Lauwers F., Fouard C., Prohaska S., Lauwers-Cances V. A novel three-dimension computer-assisted method for a quantitative study of microvascular networks of the human cerebral cortex. Microcirculation 2006, 13:1-18.
24. Cassot F., Lauwers F., Lorthois S., Puwanarajah P., Duvernoy H. Scaling laws for branching vessels of human cerebral cortex. Microcirculation 2009, 16:331-346.
25. Castelli C., Losa G.A. Ultrastructural complexity of nuclear components during early apoptotic phases in breast cancer cells. Anal. Cell. Pathol. 2001, 23:1-9.
26. Chaigneau E., Oheim M., Audinat E., Charpak S. Two-photon imaging of capillary blood flow in olfactory bulb glomeruli. Proc. Natl Acad. Sci. USA 2003, 10:13081-13806.
27. Cross S.S. The application of fractal geometric analysis to microscopic images. Micron 1994, 25:101-113.
28. Cross S.S. Fractals in pathology. J. Pathol. 1997, 182:1-8.
29. Cross S.S., Start R.D., Silcocks P.B., Bull A.D., Cotton D.W., Underwood J.C. Quantitation of the renal arterial tree by fractal analysis. J. Pathol. 1993, 170:479-484.
30. Cross S.S., Bury J.P., Silcocks P.B., Stephenson T.J., Cotton D.W. Fractal geometric analysis of colorectal polyps. J. Pathol. 1994, 172:317-323.
31. Cross S.S., Start R.D., Stephenson T.J., Cotton D.W., Variend S., Underwood J.C. Fractal geometric analysis of the renal arterial tree in infants and fetuses. Pediatr. Pathol. Lab. Med. 1995, 15:259-268.
32. Dales J.P., Garcia S., Andrac L., et al. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome. Int. J. Oncol. 2004, 24:1197-1204.
33. de la Taille A., Katz A.E., Bagiella E., et al. Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31. Am. J. Clin. Pathol. 2000, 113:555-562.
34. Debergh I., Van Damme N., Pattyn P., Peeters M., Ceelen W.P. The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model. Br. J. Cancer 2010, 102:837-843.
35. Dey P. Basic principles and applications of fractal geometry in pathology: a review. Anal. Quant. Cytol. Histol. 2005, 27:284-290.
36. Di Ieva A., Grizzi F. Microvessel density. (Letter to the Editor). J. Neurosurg. Pediatr. 2010, 6:304-306.
37. Di Ieva A., Grizzi F., Ceva-Grimaldi G., et al. Fractal dimension as a quantitator of the microvasculature of normal and adenomatous pituitary tissue. J. Anat. 2007, 211:673-680.
38. Di Ieva A., Grizzi F., Gaetani P., et al. Euclidean and fractal geometry of microvascular network in normal and neoplastic pituitary tissue. Neurosurg. Rev. 2008, 31:271-281.
39. Di Ieva A., Grizzi F., Tschabitscher M., et al. Correlation of microvascular fractal dimension with positron emission tomography [11C]-methionine uptake in glioblastoma multiforme: preliminary findings. Microvasc. Res. 2010, 80:267-273.
40. Di Ieva, A., Grizzi, F., Aimar, E., et al., (in press). The microvascular network of the pituitary gland: a model for the application of fractal geometry to the analysis of angioarchitecture and angiogenesis of brain tumors. J. Neurosurg. Sci.
41. Dollinger J.W., Metzler R., Nonnenmacher T.F. Bi-asymptotic fractals: fractals between lower and upper bounds. J. Phys. A: Math. Gen. 1998, 31:3839-3847.
42. Duvernoy H.M. An angioarchitectonic study of the brain. Anat. Clin. 1979, 1:207-222.
43. Duvernoy H.M. Comments on the microvascularization of the brain. Cerebrovasc. Dis. 2006, 21:423-424.
44. Eberhard A., Kahlert S., Goede V., Hemmerlein B., Plate K.H., Augustin H.G. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res. 2000, 60:1388-1393.
45. Espinoza-Valdez A., Femat R., Ordaz-Salazar F.C. A model for renal arterial branching based on graph theory. Math. Biosci. 2010, 225:36-43.
46. Falconer K. Fractal Geometry, Mathematical Foundations and Applications 1990, John Wiley & Sons, New York.
47. Falconer K. Techniques in Fractal Geometry 1997, John Wiley & Sons, Chichester.
48. Feder J. Fractals 1988, Planum Press, New York, NY.
49. Folkerth R.D. Descriptive analysis and quantification of angiogenesis in human brain tumors. J. Neurooncol. 2000, 50:165-172.
50. Fox S.B., Leek R.D., Weekes M.P., Whitehouse R.M., Gatter K.C., Harris A.L. Quantification and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J. Pathol. 1995, 177:275-283.
51. Fractals and medicine (Editorial) Lancet 1991, 338:1425-1426.
52. Frontczak-Baniewicz M., Czajkowska D., Andrychowski J., Walski M. The immature endothelial cell in human glioma. Ultrastructural features of blood capillary vessels. Folia Neuropathol. 2008, 46:49-56.
53. Min/+ Mice. Microsc. Microanal. 2010, 16:73-79.
54. Gazit Y., Baish J.W., Safabakhsh N., Leunig M., Baxter L.T., Jain R.K. Fractal characteristics of tumor vascular architecture during tumor growth and regression. Microcirculation 1997, 4:395-402.
55. Goldberger A.L., West B.J. Fractals in physiology and medicine. Yale J. Biol. Med. 1987, 60:421-435.
56. Grasman J., Brascamp J.W., Van Leeuwen J.L., Van Putten B. The multifractal structure of arterial trees. J. Theor. Biol. 2003, 220:75-82.
57. Grizzi F., Colombo P., Barbieri B., et al. Correspondence re: Sabo et al., Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin. Cancer Res. 2001, 7:533-537.
58. Grizzi F., Russo C., Colombo P., et al. Quantitative evaluation and modeling of two-dimensional neovascular network complexity: the surface fractal dimension. BMC Cancer 2005, 8(5):14.
59. Grizzi F., Colombo P., Taverna G., et al. Geometry of human vascular system: is it an obstacle for quantifying anti-angiogenic therapies?. Appl. Immunohistochem. Mol. Morphol. 2007, 15:134-139.
60. Grizzi F., Weber C., Di Ieva A. Antiangiogenic strategies in medulloblastoma: reality or mystery?. Pediatr. Res. 2008, 63:584-590.
61. Guidolin D., Vacca A., Nussdorfer G.G., Ribatti D. A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the Matrigel assay in vitro. Microvasc. Res. 2004, 67:117-124.
62. Hainfellner J.A., Heinzl H. Neuropathological biomarker candidates in brain tumors: key issues for translational efficiency. Clin. Neuropathol. 2010, 29:41-54.
63. Hastings H.M., Sugihara G. Fractals. A User's Guide for the Natural Sciences 1993, Oxford Science Publications, Oxford.
64. Hlatky L., Hahnfeldt P., Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J. Natl Cancer Inst. 2002, 19:883-893.
65. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005, 307:58-62.
66. Jain R.K., Munn L.M., Fukumura D. Dissecting tumour pathophysiology using intravital microscopy. Nat. Rev. Cancer 2002, 2:266-276.
67. Jain R.K., di Tomaso E., Duda D.G., Loeffler J.S., Sorensen A.G., Batchelor T.T. Angiogenesis in brain tumours. Nat. Rev. Neurosci. 2007, 8:610-622.
68. Kedzia A., Rybaczuk M., Andrzejak R. Fractal dimensions of human brain cortex vessels during the fetal period. Med. Sci. Monit. 2002, 8:46-51.
69. Keipes M., Ries F., Dicato M. Of the British coastline and the interest of fractals in medicine. Biomed. Pharmacother. 1993, 47:409-415.
70. Kirchner L.M., Schmidt S.P., Gruber B.S. Quantitation of angiogenesis in the chick chorioallantoic membrane model using fractal analysis. Microvasc. Res. 1996, 51:2-14.
71. Kleihues P., Burger P.C., Aldape K.D., et al. Glioblastoma. WHO Classification of Tumours of the Central Nervous System 2007, IARC, Lyon. D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee (Eds.).
72. Korkolopoulou P., Patsouris E., Kavantzas N., et al. Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms. Neuropathol. Appl. Neurobiol. 2002, 28:57-66.
73. Lafuente J.V., Adán B., Alkiza K., Garibi J.M., Rossi M., Cruz-Sánchez F.F. Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas. J. Mol. Neurosci. 1999, 13:177-185.
74. Lakka S.S., Rao J.S. Antiangiogenic therapy in brain tumors. Expert Rev. Neurother. 2008, 8:1457-14773.
75. Lamborn K.R., Chang S.M., Prados M.D. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neurol. Oncol. 2004, 6:227-235.
76. Landini G., Rippin J. Fractal dimension of the epithelial connective tissue interfaces in premalignant and malignant epithelial lesions of the floor of the mouth. Anal. Quant. Cytol. Histol. 1993, 15:144-149.
77. Landini G., Rippin J. How important is tumour shape? Quantification of the epithelial-connective tissue interface in oral lesions using local connected fractal dimension analysis. J. Pathol. 1996, 179:210-217.
78. Lazarovici P., Gazit A., Staniszewska I., Marcinikiewicz C., Lelkes P.I. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane. Endothelium 2006, 13:51-59.
79. Leon S.P., Folkerth R.D., Black P.M. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996, 77:362-372.
80. Lorthois S., Cassot F. Fractal analysis of vascular networks: insights from morphogenesis. J. Theor. Biol. 2010, 262:614-633.
81. Losa G.A. The fractal geometry of life. Riv. Biol. 2009, 102:29-59.
82. Losa G.A., Castelli C. Nuclear patterns of human breast cancer cells during apoptosis: characterisation by fractal dimension and co-occurrence matrix statistics. Cell Tissue Res. 2005, 322:257-267.
83. Losa G.A., Nonnenmacher T.F. Self-similarity and fractal irregularity in pathologic tissues. Mod. Pathol. 1996, 9:174-182.
84. Mainster M.A. The fractal properties of retinal vessels: embryological and clinical implications. Eye 1990, 4:235-241.
85. Mancardi D., Varetto G., Bucci E., Maniero F., Guiot C. Fractal parameters and vascular networks: facts and artifacts. Theor. Biol. Med. Model. 2008, 17:5-12.
86. Mandelbrot B.B. How long is the coast of Britain? Statistical self-similarity and fractional dimension. Science 1967, 156:636-638.
87. Mandelbrot B.B. The fractal Geometry of Nature 1982, WH. Freeman, New York.
88. Martín-Landrove M., Pereira D., Caldeira M.E., Itriago S., Juliac M. Fractal analysis of tumoral lesions in brain. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2007, 2007:1306-1309.
89. McDonald D.M., Baluk P. Significance of blood vessels leakiness in cancer. Cancer Res. 2002, 62:5381-5385.
90. McKay T.L., Gedeon D.J., Vickerman M.B., et al. Selective inhibition of angiogenesis in small blood vessels and decrease in vessel diameter throughout the vascular tree by trimcinolone acetonide. Invest. Ophtalmol. Vis. Sci. 2008, 49:1184-1190.
91. Parikh A., Smith J.K., Ewend M.G., et al. Correlation of MR perfusion imaging and vessel tortuosity parameters in assessment of intracranial neoplasms. Technol. Cancer Res. Treat. 2004, 3:585-590.
92. Parsons-Wingerter P., Lwai B., Yang M.C., et al. A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection. Microvasc. Res. 1998, 55:201-214.
93. Parsons-Wingerter P., Elliott K.E., Clark J.L., Farr A.G. Fibroblast growth factor-2 selectively stimulates angiogenesis of small vessels in arterial tree. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1250-1256.
94. Parsons-Wingerter P., Elliott K.E., Farr A.G., Radhakrishnan K., Clark J.I., Sage E.H. Generational analysis reveals that TGF-beta1 inhibits the rate of angiogenesis in vivo by selective decrease in the number of new vessels. Microvasc. Res. 2000, 59:221-232.
95. Paumgartner D., Losa G., Weibel E.R. Resolution effect on the stereological estimation of surface and volume and its interpretation in terms of fractal dimensions. J. Microsc. 1981, 121:51-63.
96. Plate K.H. Gene therapy of malignant glioma via inhibition of tumor angiogenesis. Cancer Metastasis Rev. 1996, 15:237-240.
97. Plate K.H. Mechanisms of angiogenesis in the brain. J. Neuropathol. Exp. Neurol. 1999, 58:313-320.
98. Plate K.H., Breier G., Risau W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol. 1994, 4:207-218.
99. Plate K.H., Breier G., Weich H.A., Mennel H.D., Risau W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int. J. Cancer 1994, 59:520-529.
100. Plouraboué F., Cloetens P., Fonta C., Steyer A., Lauwers F., Marc-Vergnes J.P. High resolution X-ray imaging of vascular networks. J. Microsc. 2004, 215:139-148.
101. Preusser M., Birner P., Hainfellner J.A. Algorithm for the standardized assessment of vascular patterns in glioblastoma specimens. Clin. Neuropathol. 2004, 23:238-240.
102. Preusser M., Heinzl H., Gelpi E., et al. Histopathologic assessment of hot-spot microvessel density and vascular patterns in glioblastoma: poor observer agreement limits clinical utility as prognostic factors. Cancer 2006, 107:162-170.
103. Rigaut J.P. An empirical formulation relating boundary length to resolution in specimens showing "non-ideally fractal" dimensions. J. Microsc. 1984, 133:41-54.
104. Rigaut J.P. Fractals in biological image analysis and vision. Gli oggetti frattali in astrofisica, biologia, fisica e matematica 1984, 111-145. Edizioni Cerfim, Locarno. G.A. Losa, D. Merlini (Eds.).
105. Rigaut J.P., Schoevaert-Brossault A.M., Downs A.M., Landini G. Asymptomatic fractals in the context of grey-scale images. J. Microsc. 1997, 189:57-63.
106. Righi M., Giacomini A., Lavazza C., Sia D., Carlo-Stella C., Gianni M. A computational approach to compare micro vessel distributions in tumors following antiangiogenic treatments. Lab. Investig. 2009, 89:1063-1070.
107. Risser L., Plouraboué F., Stever A., Cloetens P., Le Duc G., Fonta C. From homogeneous to fractal normal and tumorous microvascular networks in the brain. J. Cereb. Blood Flow Metab. 2007, 27:293-303.
108. Rybaczuk M., Kedzia A., Paradowski L. Fractal characteristic of brain vessel microangioarchitecture during the fetal period. Med. Sci. Monit. 2002, 8:145-152.
109. Sharma S., Sharma M.C., Sarkar C. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 2005, 46:481-489.
110. Sharma S., Sharma M.C., Gupta D.K., Sarkar C. Angiogenic patterns and their quantitation in high grade astrocytic tumors. J. Neurooncol. 2006, 79:19-30.
111. Tambasco M., Costello B.M., Kouznetsov A., Yau A., Magliocco A.M. Quantifying the architectural complexity of microscopic images of histology specimens. Micron 2009, 40:486-494.
112. Tanaka F., Otake Y., Yanagihara K., et al. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Clin. Cancer Res. 2001, 7:3410-3415.
113. Tandle A., Blazer D.G., Libutti S.K. Antiangiogenic gene therapy of cancer: recent developments. J. Transl. Med. 2004, 2:22.
114. Thamrin C., Stern G., Frey U. Fractals for physicians. Paediatr. Respir. Rev. 2010, 11:123-131.
115. Ushijima C., Tsukamoto S., Yamakazi K., Yoshino I., Sugio K., Sugimachi K. High vascularity in the peripheral region of non-small cell lung cancer tissue is associated with tumor progression. Lung Cancer 2001, 34:233-241.
116. Vajkoczy P., Menger M.D. Vascular microenvironment in gliomas. Cancer Treat. Res. 2004, 117:249-262.
117. Vakoc B.J., Lanning R.M., Tyrrell J.A., et al. Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging. Nat. Med. 2009, 10:1219-1223.
118. Vickerman M.B., Keith P.A., McKay T.L., et al. VESGEN 2D: automated, user-interactive software for quantification and mapping of angiogenic and lymphangiogenic trees and networks. Anat. Rec. 2009, 292:320-332.
119. Vico P.G., Kyriacos S., Heymans O., Louryan S., Cartilier L. Dynamic study of the extraembryonic vascular network of the chick embryo by fractal analysis. J. Theor. Biol. 1998, 195:525-532.
120. Wardlaw G., Wong R., Noseworthy M.D. Identification of intratumour low frequency microvascular components via BOLD signal fractal dimension mapping. Phys. Med. 2008, 24:87-91.
121. Warren B.A. The vascular morphology of tumors. Tumor Blood Circulation: angiogenesis, vascular morphology and blood flow of experimental and human tumors 1979, 1-47. CRC Press Inc., Boca Raton, FL. H.-I. Peterson (Ed.).
122. Weibel E.R. Design of biological organisms and fractal geometry. Fractals in Biology and Medicine 1994, Vol. I. Birkhaeuser Press, Basel-Berlin-Boston.
123. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J. Med. 1991, 324:1-8.
124. Weidner N., Folkman J., Pozza F., et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl Cancer Inst. 1992, 84:1875-1887.
125. Weidner N., Carroll P.R., Flax J., Blumenfeld W., Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 1993, 143:401-409.
126. Wesseling P., van der Laak J., Link M., Methorst A.J., Teepen H., Ruiter D.J. Quantitative analysis of microvascular changes during malignant progression in astrocytic neoplasms (abstract). J. Neuropathol. Exp. Neurol. 1996, 55:607.
127. Wesseling P., Van Der Laak J., Link M., Teepen H., Ruiter D.J. Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy. Hum. Pathol. 1998, 29:352-358.
128. West B.J. Fractal forms in physiology. Int. J. Mod. Phys. 1990, B4:1629-1669.
129. WIKIPEDIA: Accessed 23 March 2010. http://en.wikipedia.org/w/index.php?title=Morphometrics&oldid=350752763.
130. Yano T., Tanikawa S., Fujie T., Masutani M., Horie T. Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer. Eur. J. Cancer 2000, 36:601-609.
131. Zamir M. On fractal properties of arterial trees. J. Theor. Biol. 1999, 197:517-526.
132. Zamir M. Fractal dimensions and multifractality in vascular branching. J. Theor. Biol. 2001, 212:183-190.
133. Zook J.M., Iftekharuddin K.M. Statistical analysis of fractal-based brain tumor detection algorithms. Magn. Reson. Imaging 2005, 23:671-678.